Jian Wang

Title: The Innovations of Jian Wang

Introduction

Jian Wang is a notable inventor based in Killingworth, CT (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on developing innovative solutions that enhance drug efficacy and safety.

Latest Patents

Wang's latest patents include "Solid dosage forms of palbociclib" and "Diacylglycerol acyltransferase 2 inhibitors." The first patent relates to solid dosage forms of palbociclib that comprise a water-soluble acid, which provides desirable pharmacokinetic characteristics. The second patent describes derivatives of purine, 3H-imidazo[4,5-b]pyrimidine, and 1H-imidazo[4,5-d]pyrazine that inhibit the activity of diacylglycerol acyltransferase 2 (DGAT2), with applications in treating related diseases in animals.

Career Highlights

Jian Wang is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Wang collaborates with talented professionals in his field, including Kay Ahn and Markus Boehm. These collaborations enhance the innovative potential of his projects and contribute to the advancement of pharmaceutical sciences.

Conclusion

Jian Wang's contributions to the field of pharmaceuticals through his patents and work at Pfizer Corporation highlight his role as an influential inventor. His innovative approaches continue to shape the future of drug development and treatment options.